Alzheimer’s drug that failed trial may still slow disease | New Scient

Page analysis provided by Secret Search Engine Labs

Alzheimer’s drug that failed trial may still slow disease | New Scient
www.newscientist.com

A drug that targets tau tangles in the brain has failed when tested as a treatment to be taken with other medication. But it may work well when taken alone

Visit Alzheimer’s drug that failed trial may still slow disease | New Scient (https://www.newscientist.com/article/2099108-unprecedented-alzheimers-drug-slows-disease-by-80-per-cent/)

CashRank™: $1.00
Tags: lang_en=47.354
Level: 3

Alexa Traffic Rank™: N/A
Google PageRank™: N/A

Top Keywords: drug, disease, drug that, failed, cent, brain, slow, trial, the brain, tangles, tau, alzheimer, per, a, scientist, lmtx, taken, in the brain, may still, a drug, per cent, alone, 80, medication, as a treatment, a treatment, has failed, when taken, treatment to, targets, with other, find us on, but it may, be taken with, to be taken, may work, Theres a total of 768 keywords.

Inbound and Outbound Links

There is a total of 1 inbound link to this page. There is currently no known outbound links.

View link details

Statistics

We first found this page on 2024-01-16 22:01:01 +0000. It was last re-indexed on 2024-10-01 20:51:07 +0000 and with a fetch interval of 90 days it will be fetched again in 90 days on 2024-12-30 or soon thereafter.

Last fetch returned code 200, OK, the current page state is ACTIVE.

Traffic Data for www.newscientist.com

Traffic data is only available for sites with a CashRank of $15 or better, an Alexa rank better than 100,000 or PageRank of 2 or more.

If you are the owner of /www.newscientist.com and you want to remove this page from the search results, just use robots.txt

Similar Sites

TauRx Alzheimer's Drug LMTX Fails in Large Study Although Some Be

The experimental Alzheimer's drug LMTX failed to improve cognitive and functional skills in patients with mild to moderate Alzheimer's.
https://www.nbcnews.com/health/health-news/taurx-alzheimer-s-drug-lmtx-fails-large-study-although-some-n617746 - Details - Similar

Mark Cuban Cost Plus Drug Co. lowers price of lifesaving drugs for Wil

Cuban’s Cost Plus Drug Co. is selling generic drugs for Wilson disease, at the urging of Drew Katz.
https://www.inquirer.com/health/mark-cuban-drug-costs-drew-katz-rare-disease-20230623.html - Details - Similar

Drug Driving - Driving Law

All about drug driving charges from Queensland's leading drug driving lawyers.
https://www.drivinglaw.com.au/services/drug-driving.html - Details - Similar

Medicilon - Preclinical Research_Drug Selection_Drug Safety Evaluation

Medicilon,a contract research organization(CRO), can provide one-stop integrated services including Biology, Chemistry and Preclinical services. Medicilon has been recognized as one of the professional drug discovery pre
https://www.medicilon.com/ - Details - Similar

More sites similar to Alzheimer’s drug that failed trial may still slow disease | New Scient...

Find Another Website

Search - Add URL

Sponsored Results

Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less

Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less

web stats

Copyright (C) 2007 - 2024 Text Ad King and SecretSearchEngineLabs.com. All Rights Reserved.
Terms and Conditions - Privacy Policy - Advertising - About Us - Login